View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | Germany |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2028-01-15 |
| Par Value | 1000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 475.00 |
| Coupon | 4.375 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 475 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Cheplapharm Arzneimittel corporate bond has a 4.38% fixed rate coupon paid on a semi-annual basis. It was issued on October 15, 2020 with an issue size of 475.00 million EUR and matures on January 15, 2028 with a last coupon date of July 15, 2027. |
Cheplapharm Arzneimittel, founded in 1998 and headquartered in Greifswald, Germany, is a leading pharmaceutical company focused on the development and distribution of generic and specialty drugs. The company aims to improve access to essential medications across multiple therapeutic areas, including cardiology, gynecology, and endocrinology. Cheplapharm's robust portfolio comprises both established compounds and innovative therapies, catering to diverse patient needs while promoting sustainable healthcare solutions.